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OBJECTIVE — To study potential risk factors for retinopathy in diabetic and nondiabetic
individuals.
RESEARCH DESIGN AND METHODS — The Hoorn Study is a population-based
study including 2,484 50- to 74-year-old Caucasians. A subsample of 626 individuals stratified
by age, sex, and glucose tolerance underwent extensive measurements during 1989–1992,
including ophthalmologic examination and two-field 45-degree fundus photography. The prev-
alence of (diabetic) retinopathy was assessed among individuals with normal glucose metabolism
(NGM) and impaired glucose metabolism (IGM) and individuals with newly diagnosed diabetes
mellitus (NDM) and known diabetes mellitus (KDM) (new World Health Organization 1999
criteria).
RESULTS — The prevalence of retinopathy was 9% in NGM, 11% in IGM, 13% in NDM, and
34% in KDM. Retinopathy worse than minimal nonproliferative diabetic retinopathy was present
in 8% in KDM and 0–2% in other glucose categories. The prevalence of retinopathy was
positively associated with elevated blood pressure, BMI, cholesterol, and triglyceride serum
levels in all glucose categories. The age-, sex-, and glucose metabolism category–adjusted odds
ratios were 1.5 (95% CI 1.2–1.9), 1.3 (1.0–1.7), and 1.3 (1.0–1.6) per SD increase of systolic
blood pressure, BMI, and total cholesterol concentration, respectively, and 1.2 (1.0–1.5) per
50% increase of triglyceride level. Elevated blood pressure and plasma total and LDL cholesterol
levels showed associations with retinal hard exudates.
CONCLUSIONS — Retinopathy is a multifactorial microvascular complication, which,
apart from hyperglycemia, is associated with blood pressure, lipid concentrations, and BMI.
Diabetes Care 25:1320–1325, 2002
There is growing evidence that reti-nopathy is not only related to hyper-glycemia and diabetes duration.
Other cardiovascular risk factors have
been shown to play an important role as
well (1–4). The U.K. Prospective Diabetes
Study (UKPDS) has shown that intensive
blood pressure treatment in hypertensive
subjects with type 2 diabetes prevented or
delayed progression of retinopathy (5).
There are also indications that elevated
serum lipid levels promote retinopathy
and especially hard exudates (6–8). Most
of these studies, however, are restricted to
diabetic patients. A number of popula-
tion-based studies have reported the pres-
ence of retinopathy in nondiabetic
subjects (9–14). However, there is only
little information about risk factors for
retinopathy in these individuals. We pre-
viously reported an association of hyper-
homocysteinemia with retinopathy in the
diabetic but not in the nondiabetic popu-
lation (15). Therefore, the aim of the
present study was to investigate the con-
tribution of blood pressure, lipids, and
obesity to retinopathy in diabetic and
nondiabetic individuals. We also specifi-
cally analyzed associations of risk factors
with hard exudates, a sight-threatening
complication when associated with mac-
ular edema. In addition, we present the
prevalence of retinopathy according to
the new diagnostic criteria for diabetes of
the World Health Organization (WHO
1999).
RESEARCH DESIGN AND
METHODS
Subjects
The study population consisted of 626
Dutch citizens, aged 50–74 years, who
underwent an ophthalmologic examina-
tion during 1989–1992. Subjects were
selected from the Hoorn Study, which has
been extensively reported elsewhere (16).
Briefly, a random selection of 3,553 sub-
jects, aged 50–74 years, from the popu-
lation register of the town of Hoorn, the
Netherlands, was invited, and 2,540 sub-
jects (71.5%) participated. After exclu-
sion of 56 non-Caucasians, the remaining
2,484 subjects formed the cohort of the
Hoorn Study, a population-based study
on glucose metabolism in a general Cau-
casian population. In this population,
fasting plasma glucose was measured and
all individuals not treated with oral blood
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glucose–lowering agents or insulin un-
derwent a 75-g oral glucose tolerance test
(OGTT). All diabetic patients treated with
oral glucose-lowering agents or insulin
(n  76) and all individuals with a 2-h
postload glucose 11.1 mmol/l (n 
122), as well as two age- and sex-stratified
random samples, from subjects with 2-h
glucose levels7.5 mmol/l (n 256) and
11.1 mmol/l but 7.5 mmol/l (n 
254), respectively, were invited for an ex-
tensive physical examination, including
ophthalmologic examination and fundus
photography. Participants who did not
receive pharmacological treatment for di-
abetes had a second OGTT within 3–5
weeks after the first OGTT.
The 626 participants (88% of those
invited) with an ophthalmologic exami-
nation or fundus photograph did not dif-
fer significantly from the nonattendees
with respect to age, self-reported hyper-
tension, and cardiovascular disease (data
not shown). The Hoorn Study was ap-
proved by the Ethical Review Committee
of the VU University Medical Center
(VUMC) in Amsterdam, the Netherlands.
Written informed consent was obtained
from all participants.
Ophthalmologic examinations and
definitions
The ophthalmologic examinations were
performed by ophthalmologists in the De-
partment of Ophthalmology of the
VUMC. All examiners were unaware of
the glucose metabolism status of the study
participants.
After mydriasis with tropicamide and
phenylephrine eye drops, the retina was
examined by funduscopy, and (diabetic)
retinopathy was graded following the
Wisconsin grading system (modified Air-
lie House classification) (17). Fundus
photography was performed with a 45-
degree Kowa Pro fundus camera with
green filter (Kowa Optical Industry, To-
kyo). Of each eye, two black-and-white
35-mm photographs (Kodak Tri-X400
ASA; Eastman Kodak, Rochester, NY)
were taken, one centered on the macula
and one nasal on the optic disc. Photo-
graphs of 148 subjects were missing (not
associated with age, sex, glucose tolerance
category, hypertension, and worst eye vi-
sual acuity; data not shown). All photo-
graphs (11  11 cm) were recently
regraded for (diabetic) retinopathy ac-
cording to the Eurodiab standards inde-
pendently by an ophthalmologically
trained physician and a senior ophthal-
mologist (H.A.v.L., B.C.P.P.). In case of
disagreement, the independent judgment
of another ophthalmologist was taken to
be decisive (A.C.M.). We used the Euro-
diab classification scheme for the photo-
graphs because this matches the available
45-degree two-field fundus photography
and because it uses standard photographs
to grade retinal lesions, whereas the Wis-
consin grading system is based on seven
fields of 30 degrees (17,18).
Retinopathy was considered present
when at least one microaneurysm, hem-
orrhage, or hard exudate was present or in
case of neovascularization, fibrous prolif-
eration, or laser coagulation scars at pho-
tographs or funduscopy. Retinopathy
worse than minimal nonproliferative dia-
betic retinopathy (NPDR) was present at
Eurodiab grade 2 or more using photog-
raphy or at Wisconsin grade 4.0 or more
with funduscopy (17,18). Hemorrhages
or exudates as symptoms of other pathol-
ogy, such as retinal venous occlusion,
were not considered as (diabetic) retinop-
athy but were analyzed separately. In each
subject the “worst eye” was graded for
each abnormality, according to ophthal-
moscopy or fundus photography.
In five individuals, none of the pho-
tographs were gradable, because of poor
quality. Of these, only one person had no
complete funduscopy report and was ex-
cluded for analysis of retinopathy.
Laboratory and other medical
assessments
Fasting and 2-h postload venous plasma
glucose levels were determined with a
glucose dehydrogenase method (Merck,
Darmstadt, Germany). For statistical
analyses, the mean of two fasting and two
2-h glucose levels (if present) was taken.
HbA1c and lipids were determined in the
fasting blood sample at the first OGTT.
HbA1c was determined by ion exchange
high-performance liquid chromatogra-
phy using a DM monitoring system (Bio-
Rad, Veenendaal, the Netherlands;
normal range 4.3–6.1%). Total choles-
terol, HDL cholesterol (after precipitation
of the low- and very low–density pro-
teins), and triglycerides were measured
by enzymatic techniques (Boehringer-
Mannheim, Mannheim, Germany). The
Friedewald formula was used to calculate
the LDL cholesterol (except for subjects
with triglycerides 4.55 mmol/l).
Systolic and diastolic (Korotkov V)
blood pressure was determined on the
right arm of seated subjects, after at least 5
min resting, using a random-zero sphyg-
momanometer. The average of four mea-
surements (duplicate recordings taken
before the start of both OGTTs) was used
for analysis. Height, weight, and waist
and hip circumferences were determined
to calculate waist-to-hip ratio (WHR) and
BMI as described elsewhere (16). Use of
medication was checked at the first visit.
Statistical analysis
Subjects were classified in categories ac-
cording to glucose metabolism. Known
diabetic individuals (KDM) with oral glu-
cose-lowering medication, insulin, or a
diet were analyzed separately. The other
subjects were classified in three groups
according to the WHO 1999 with fasting
plasma glucose 6.1 mmol/l and 2-h
postload glucose7.8 mmol/l for normal
glucose metabolism (NGM), fasting glu-
cose 6.1–7.0 mmol/l or 2-h glucose 7.8–
11.1 mmol/l for impaired glucose
metabolism (IGM), and fasting glucose
7.0 mmol/l or 2-h glucose 11.1
mmol/l for newly diagnosed diabetes
(NDM).
After stratification for glucose metab-
olism categories, the prevalences of reti-
nopathy, retinopathy worse than minimal
NPDR, and hard exudates were calcu-
lated. The prevalence of retinopathy was
studied in approximate tertiles (based on
the total study population distribution) of
blood pressure, BMI, and cholesterol and
triglyceride concentrations, separately in
each glucose metabolism category. By lo-
gistic regression analysis, age- and sex-
adjusted odds ratios for retinopathy were
calculated for categories of glucose me-
tabolism compared with NGM. Subse-
quently, age- and sex-adjusted odds ratios
were calculated for tertiles of blood pres-
sure, BMI, total cholesterol, and triglycer-
ide concentrations in separate models,
with the lowest tertile as the reference cat-
egory. In this analysis, individuals with
diabetes (NGM and KDM) and without
diabetes (NGM and IGM) were taken to-
gether, with adjustment for IGM in the
nondiabetic group and for KDM in the
diabetic group. We tested for possible in-
teractions of blood pressure, lipids, and
BMI with the glucose metabolism catego-
ries. Finally, associations of retinopathy,
retinopathy worse than minimal NPDR,
and retinopathy with hard exudates, re-
spectively, with blood pressure, choles-
van Leiden and Associates
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terol, triglycerides, BMI, and WHR as
continuous variables were analyzed by lo-
gistic regression separately, after adjust-
ing for age, sex, and the categories of
glucose metabolism. Triglyceride levels
were log-transformed for this analysis, be-
cause of its skewed distribution. There-
fore, odds ratios for triglycerides were
calculated per 50% increase of serum
level. In all analyses SPSS 9.0 was used. P
values 0.05 are considered to be statis-
tically significant, and all odds ratios are
presented with corresponding 95% con-
fidence intervals.
RESULTS — Table 1 shows the main
characteristics of our study population in
the four categories of glucose metabolism.
The prevalence of retinopathy increased
from 9% in individuals with NGM to 13%
in individuals with NDM and was signif-
icantly higher (34%) among individuals
with KDM. Only five individuals had
symptoms of proliferative retinopathy or
retinopathy with photocoagulation scars.
The prevalence of retinopathy with hard
exudates was 2% in those with NGM,
5–6% in those with IGM or NDM, and
13% in subjects with KDM (Table 1). Af-
ter adjustment for age and sex, the odds
ratios for the presence of retinopathy were
1.23 (95% CI 0.66–2.31), 1.42 (0.71–
2.84), and 4.72 (2.50 – 8.93) in IGM,
NDM, and KDM, respectively, compared
with NGM.
Figure 1 shows the prevalence of ret-
inopathy in categories of systolic blood
pressure, total cholesterol and triglycer-
ide concentrations, and BMI after stratifi-
cation for glucose metabolism category.
The prevalence of retinopathy was associ-
ated with systolic blood pressure. Espe-
cially in NGM and KDM groups, we
established a positive trend (P values for
trend 0.05 and 0.07, respectively; Fig.
1A). The results for diastolic blood pres-
sure were similar (data not shown). We
found a positive association of total and
LDL cholesterol with retinopathy, espe-
cially in the IGM and NDM groups (P val-
ues for trend 0.01 and 0.31, respectively,
for cholesterol; Fig. 1B; data for LDL cho-
lesterol not shown but similar). Positive
trends in the prevalence of retinopathy for
BMI and triglyceride levels were less con-
sistent in the different glucose metabo-
lism groups (Figs. 1C and 1D).
Logistic regression analysis showed
that in individuals with (but also in indi-
viduals without) diabetes, the highest
risks for retinopathy were present in the
highest tertiles of blood pressure and total
cholesterol and triglyceride concentration
(Table 2). Actual blood pressure, but not
the use of antihypertensives, was posi-
tively associated with retinopathy. Asso-
ciations of lipid levels and blood pressure
with retinopathy were somewhat stronger
in individuals without diabetes than in in-
dividuals with diabetes. BMI was posi-
tively associated with retinopathy in
individuals with diabetes.
Because the associations between
prevalence of retinopathy and risk factors
were similar in most categories of glucose
metabolism and no consistent significant
interactions were observed, we subse-
quently combined all glucose metabolism
categories (Table 3). After adjustment for
age, sex, glucose metabolism category,
and use of antihypertensive medication,
the odds ratios for retinopathy per 1 SD
increase of systolic or diastolic blood
pressure were 1.48 and 1.39, respec-
tively. Odds ratios were even higher when
we considered retinopathy worse than
minimal NPDR. Use of antihypertensive
medication was positively associated with
retinopathy worse than NPDR, although
not statistically significant. An increase of
total or LDL cholesterol, triglyceride lev-
els, or BMI was associated with elevated
risks for retinopathy as well. Lipid levels
and BMI, however, were not associated
with retinopathy worse than minimal
NPDR. Systolic and diastolic blood pres-
sure, as well as total and LDL cholesterol,
were positively associated with the pres-
ence of retinopathy with hard exudates;
all with odds ratios of 1.6 per SD increase
(Table 3). HDL cholesterol and WHR,
however, did not show a clear relation-
ship with retinopathy. Finally we com-
bined glucose metabolism categories,
systolic blood pressure, use of antihyper-
Table 1—General and ophthalmologic characteristics of the study population
NGM IGM NDM KDM
n 256 177 115 78
Age (years) 63.3  7.4 64.2  7.3 65.7  6.6 65.5  6.8
Sex (% female) 51 49 51 62
Fasting glucose (mmol/l) 5.3  0.4 6.0  0.5 8.2  2.9 10.6  3.7
2-h glucose (mmol/l) 5.6  1.4 8.6  1.4 14.4  5.6 15.8  4.9*
HbA1c (%) 5.3  0.5 5.6  0.5 6.6  1.7 7.8  1.6
Total cholesterol (mmol/l) 6.6  1.2 6.7  1.1 6.5  1.3 6.5  1.3
HDL cholesterol (mmol/l) 1.4  0.4 1.3  0.4† 1.1  0.3 1.2  0.3†
LDL cholesterol (mmol/l) 4.6  1.1‡ 4.6  1.0§ 4.4  1.2 4.3  0.9¶
Triglycerides (mmol/l) 1.3 (1.0–1.8) 1.6 (1.2–2.2) 2.0 (1.4–2.8) 1.9 (1.3–2.8)†
Systolic BP (mmHg) 133  18 143  20 145  17 144  21
Diastolic BP (mmHg) 81  10 84  10 84  9 82  11
% With antihypertensives 17 31 34 51
WHR 0.89  0.08† 0.93  0.09 0.95  0.08‡ 0.94  0.07†
BMI (kg/m2) 25.9  3.2 27.5  3.7 28.7  4.0 28.8  5.1†
Retinopathy (%) 9 11 13 34†
Minimal NPDR (%) 1 2 0 8†
Hard exudates (%) 2 6 5 13†
Data are means or % SD and median (interquartile range) for triglycerides. BP, blood pressure;Minimal NPDR, retinopathy worse than minimal nonproliferative
diabetic retinopathy. *Subjects with diet only (n  12); number of missing subjects: †1, ‡2, §4, 9, ¶7.
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tensive medication, BMI, and total choles-
terol and triglyceride levels in one model,
in which we adjusted for age and sex (data
not shown). Both KDM and systolic blood
pressure were significantly and indepen-
dently associated with retinopathy. BMI
and triglyceride and cholesterol concen-
trations did not reach statistical signifi-
cance, but the odds ratios were only
slightly lower than in the age-, sex-, and
glucose metabolism category–adjusted
model of Table 3.
CONCLUSIONS — This population-
based cross-sectional study showed that,
in addition to glycemic variables, blood
pressure, BMI, and cholesterol and tri-
glyceride concentrations are associated
with retinopathy as well.
Our study had some limitations. It is
well known that volunteers who partici-
pate in a population study are generally
healthier than nonparticipants. There-
fore, we may have underestimated the
true prevalence of retinopathy. We com-
bined findings of funduscopy with those
of fundus photography to enhance the
sensitivity. Fundus photography has been
shown to be valuable in detecting early
retinopathy, while on the other hand, le-
sions outside the two central fundus fields
and small lesions on 45-degree fundus
photographs might be missed (19,20).
Therefore, the two methods are comple-
mentary.
In the present study, the prevalence
of retinopathy among non-KDM individ-
uals was higher than that reported in the
Californian Rancho Bernando and Finn-
ish Oulu Studies and in Pima Indians, in
which prevalences 4% were reported
(12–14). The prevalence of retinopathy
among 3,654 subjects without diabetes
aged 45 years in the Blue Mountains
Eye Study was similar to that in our study
(9.8%) (10). The prevalence of retinopa-
thy in the Beaver Dam Eye Study popula-
tion without diabetes was 7.8%, while
among Hispanic Americans without
diabetes aged 40 years, the prevalence
was 17.5% (9,11). Differences between
studies may be due to differences in pop-
ulation characteristics (like age and eth-
nicity), techniques and definitions used to
detect retinopathy, and the definition of
diabetes. In our study, individuals with
only one to three microaneurysms or dot
hemorrhages were already considered to
have retinopathy, because even one or
two microaneurysms have been reported
to be predictive for progression of reti-
nopathy (21). Indeed the prevalence of
retinopathy worse than minimal NPDR
Figure 1—Prevalence of retinopathy among tertiles of systolic blood pressure (A), total cholesterol (B), triglycerides (C), and BMI (D), stratificated
for glucose metabolism.
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was only 0–2% in individuals without
KDM. Small hemorrhages could mimic
nonspecific early symptoms of hyperten-
sive vascular changes. In diabetic subjects
these lesions are usually classified as reti-
nopathy. Such lesions were observed in
nondiabetic individuals in our study and
in other studies and indicate that risk fac-
tors other than hyperglycemia may also
play a role (9–14). Blood pressure, but
not lipids or (central) obesity, however,
appears to be a risk factor for retinopathy
worse than minimal NPDR.
In the UKPDS, associations were
found between retinopathy and blood
pressure in subjects with a fasting glucose
level of at least 6.1 mmol/l (3–5). Our
study extends this observation by show-
ing that blood pressure is also associated
with retinopathy in individuals with
NGM (Fig. 1). Antihypertensive medica-
tion was not associated with higher risk of
retinopathy. In contrast, retinopathy
worse than minimal NPDR did show a
positive association, although not statisti-
cally significant (Table 3). Possibly these
more severe levels of retinopathy are due
to long-lasting hypertension, resulting in
current use of antihypertensives. Further-
more, we showed that retinopathy, and
hard exudates in retinopathy in particu-
lar, are related to elevated serum (LDL)
cholesterol levels, which supports earlier
results from diabetic patients in the Wis-
consin Epidemiologic Study of Diabetic
Retinopathy and the Early Treatment Di-
abetic Retinopathy Study, and expands
these findings to individuals without dia-
betes (6,7). Lipid lowering may have ben-
eficial effects on ocular morbidity, as has
been mentioned before in an above-
mentioned study with diabetic patients
(7). Associations between triglyceride lev-
els or BMI and retinopathy, as observed in
this study, were reported among type 1
diabetic patients in the EURODIAB Study
(8). Other studies, however, showed no
statistically significant or even inverse as-
sociations between BMI and retinopathy
(1–3,12).
This cross-sectional study suggests
that retinopathy is a multifactorial micro-
vascular complication, involving not only
glucose metabolism but also lipid metab-
olism, blood pressure, and BMI. Increased
capillary permeability, microaneurysm
formation, capillary closure, and retinal
ischemia are probably due to the com-
bined effects of the various risk factors.
Table 2—Odds ratios for retinopathy in persons without diabetes (NGM and IGM) and with
diabetes (NDM and KDM) for each risk factor separately
Risk factor No diabetes Diabetes
Age (per 10 years) 1.01 (0.66–1.55) 1.31 (0.77–2.22)
Sex (female vs. male) 1.34 (0.71–2.51) 1.50 (0.74–3.05)
Systolic BP* (mmHg)
93–129 1 1
129.5–145.5 2.03 (0.87–4.77) 0.93 (0.30–2.87)
146–219.5 3.01 (1.24–7.28) 1.85 (0.69–4.99)
Use of antihypertensives 0.76 (0.34–1.66) 0.90 (0.42–1.93)
Diastolic BP* (mmHg)
52.5–78 1 1
78.5–85.5 1.95 (0.82–4.63) 0.66 (0.25–1.79)
86–127 2.63 (1.13–6.12) 1.80 (0.74–4.38)
Use of antihypertensives 0.79 (0.36–1.72) 0.87 (0.40–1.89)
Total cholesterol (mmol/l)
3.1–6.0 1 1
6.1–7.1 1.85 (0.77–4.48) 1.47 (0.59–3.63)
7.2–11.9 2.61 (1.10–6.21) 1.76 (0.69–4.49)
Triglycerides (mmol/l)
0.4–1.2 1 1
1.3–1.9 0.82 (0.36–1.88) 0.65 (0.21–2.03)
2.0–14.0 2.24 (1.03–4.91) 1.52 (0.57–4.04)
BMI (kg/m2)
15.4–24.5 1 1
25.5–28.4 1.14 (0.54–2.45) 2.55 (0.71–9.11)
28.4–45.7 1.27 (0.57–2.83) 3.52 (1.05–11.8)
Data are odds ratios (95% CI) among tertiles of blood pressure (BP), lipids, and BMI, related to the lowest
tertile; adjusted for age and sex (age and sex not adjusted), for IGM in no diabetes and for KDM in diabetes.
*For blood pressure additionally adjusted for use of antihypertensives.
Table 3—Odds ratios for retinopathy, retinopathy worse than minimal nonproliferative diabetic retinopathy, and hard exudates for each risk
factor separately
Risk factor Retinopathy  Minimal NPDR Hard exudates
Systolic BP (19.5 mmHg)* 1.48 (1.17–1.86) 2.14 (1.21–3.80) 1.60 (1.13–2.25)
Use of antihypertensives 0.85 (0.50–1.47) 1.84 (0.51–6.61) 0.75 (0.33–1.70)
Diastolic BP (10.0 mmHg)* 1.39 (1.10–1.76) 1.84 (1.08–3.12) 1.62 (1.16–2.26)
Use of antihypertensives 0.89 (0.52–1.51) 2.06 (0.59–7.23) 0.79 (0.35–1.78)
Total cholesterol (1.19 mmol/l) 1.29 (1.02–1.62) 1.02 (0.57–1.85) 1.59 (1.13–2.23)
HDL cholesterol (0.36 mmol/l) 0.98 (0.75–1.28) 1.05 (0.56–1.96) 1.03 (0.69–1.53)
LDL cholesterol (1.05 mmol/l) 1.25 (0.98–1.59) 1.12 (0.58–2.13) 1.63 (1.12–2.37)
Triglycerides (50%) 1.24 (1.03–1.51) 0.96 (0.61–1.49) 1.23 (0.93–1.62)
BMI (3.96 kg/m2) 1.31 (1.04–1.66) 1.05 (0.59–1.88) 0.98 (0.69–1.40)
WHR (0.0864) 1.15 (0.84–1.57) 1.15 (0.52–2.56) 1.40 (0.87–2.27)
Odds ratios (95% CI) per 1 SD increase (between brackets) or per 50% increase (triglycerides) after adjustment for age, sex, and glucose metabolism category. *For
blood pressure additionally adjusted for use of antihypertensives; BP, blood pressure.
BP, lipids, and obesity are linked with retinopathy
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Subjects with cardiovascular risk factors,
like elevated blood pressure, BMI, or se-
rum lipid levels, should be given more
frequent ophthalmologic examinations.
Alternatively, diagnosis of above-
mentioned vascular retinal changes
should lead to further examination for
risk factors like hypertension, dyslipide-
mia, and accompanying atherosclerosis.
Thus, appropriate (combined) therapy in
an early phase not only prevents symp-
tomatic cardiovascular morbidity and
mortality, but may also contribute to the
prevention of retinopathy.
In conclusion, the present study
shows that besides hyperglycemia, also
blood pressure, obesity, and elevated se-
rum cholesterol and triglyceride levels are
associated with (prevalent) retinopathy.
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